State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2

Bibliographic Details
Main Authors:	J. Francis Borgio, Hind Saleh Alsuwat, Waad Mohammed Al Otaibi, Abdallah M. Ibrahim, Noor Almandil, Lubna Ibrahim Al Asoom, Mohammed Salahuddin, Balu Kamaraj, Sayed AbdulAzeez
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-04-01
Series:	Archives of Medical Science
Subjects:	covid-19 sars-cov-2 clinically approved drugs molecular docking helicase antiretroviral agents
Online Access:	https://www.termedia.pl/State-of-the-art-tools-unveil-potent-drug-targets-amongst-clinically-approved-drugs-to-inhibit-helicase-in-SARS-CoV-2,19,40407,1,1.html

id	doaj-d27ef40f7a1a49f0869108e5618263bc
record_format	Article
spelling	doaj-d27ef40f7a1a49f0869108e5618263bc2020-11-25T02:49:28ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512020-04-0116350851810.5114/aoms.2020.9456740407State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2J. Francis BorgioHind Saleh AlsuwatWaad Mohammed Al OtaibiAbdallah M. IbrahimNoor AlmandilLubna Ibrahim Al AsoomMohammed SalahuddinBalu KamarajSayed AbdulAzeezhttps://www.termedia.pl/State-of-the-art-tools-unveil-potent-drug-targets-amongst-clinically-approved-drugs-to-inhibit-helicase-in-SARS-CoV-2,19,40407,1,1.htmlcovid-19 sars-cov-2 clinically approved drugs molecular docking helicase antiretroviral agents
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	J. Francis Borgio Hind Saleh Alsuwat Waad Mohammed Al Otaibi Abdallah M. Ibrahim Noor Almandil Lubna Ibrahim Al Asoom Mohammed Salahuddin Balu Kamaraj Sayed AbdulAzeez
spellingShingle	J. Francis Borgio Hind Saleh Alsuwat Waad Mohammed Al Otaibi Abdallah M. Ibrahim Noor Almandil Lubna Ibrahim Al Asoom Mohammed Salahuddin Balu Kamaraj Sayed AbdulAzeez State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2 Archives of Medical Science covid-19 sars-cov-2 clinically approved drugs molecular docking helicase antiretroviral agents
author_facet	J. Francis Borgio Hind Saleh Alsuwat Waad Mohammed Al Otaibi Abdallah M. Ibrahim Noor Almandil Lubna Ibrahim Al Asoom Mohammed Salahuddin Balu Kamaraj Sayed AbdulAzeez
author_sort	J. Francis Borgio
title	State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
title_short	State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
title_full	State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
title_fullStr	State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
title_full_unstemmed	State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
title_sort	state-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in sars-cov-2
publisher	Termedia Publishing House
series	Archives of Medical Science
issn	1734-1922 1896-9151
publishDate	2020-04-01
topic	covid-19 sars-cov-2 clinically approved drugs molecular docking helicase antiretroviral agents
url	https://www.termedia.pl/State-of-the-art-tools-unveil-potent-drug-targets-amongst-clinically-approved-drugs-to-inhibit-helicase-in-SARS-CoV-2,19,40407,1,1.html
work_keys_str_mv	AT jfrancisborgio stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT hindsalehalsuwat stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT waadmohammedalotaibi stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT abdallahmibrahim stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT nooralmandil stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT lubnaibrahimalasoom stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT mohammedsalahuddin stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT balukamaraj stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2 AT sayedabdulazeez stateofthearttoolsunveilpotentdrugtargetsamongstclinicallyapproveddrugstoinhibithelicaseinsarscov2
_version_	1724743209954836480

State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2

Similar Items